Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LKA-651 by Novartis for Diabetic Macular Edema: Likelihood of Approval
LKA-651 is under clinical development by Novartis and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase...